Markets Stocks

22.05 EUR +0.15 +0.68%
03:59:55 PM EDT 6/13/2025 STU


CompuGroup Medical Stock Snapshot

1.32 B
Market Cap in USD
51.73 M
Number of Shares
51.73 M
Total Number of Shares
0.05
Dividend in EUR
0.23
Dividend Yield
32.62
P/E Ratio
15.81
Free Float in %
0.67
EPS in EUR
12.52
Book Value per Share in EUR
2.44
Cash Flow per Share in EUR

Historical Prices for CompuGroup Medical

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

CompuGroup Medical Analyst Opinions

Date Analyst Rating Price

CompuGroup Medical Estimates* in EUR

  2025 2026 2027 2028 2029
Revenue 1,193 1,234 1,260 - -
Dividend 0.32 0.35 0.09 - -
Dividend Yield (in %) 1.45 % 1.59 % 0.41 % - -
EPS 1.36 1.58 1.81 - -
P/E Ratio 16.24 13.95 12.18 - -
EBIT 134 149 143 - -
EBITDA 239 257 262 258 267
Net Profit 64 77 81 - -
Net Profit Adjusted 87 98 94 - -
Pre-Tax Profit 101 118 117 - -
Pre-Tax Profit Reported 70 85 109 - -
EPS (Non-GAAP) ex. SOE - - - - -
EPS (GAAP) 1.07 1.32 1.56 - -
Gross Income 1,010 1,041 1,072 - -
Cash Flow from Investing -85 -83 -84 - -
Cash Flow from Operations 157 186 201 - -
Cash Flow from Financing -65 -26 -29 - -
Cash Flow per Share 1.87 2.60 2.97 - -
Free Cash Flow 73 102 117 174 178
Free Cash Flow per Share 1.74 2.15 2.54 - -
Book Value per Share 12.66 13.62 15.82 - -
Net Debt 696 624 530 422 324
Research & Development Exp. - - - - -
Capital Expenditure 72 73 68 - -
Selling, General & Admin. Exp. - - - - -
Shareholder’s Equity 663 722 838 - -
Total Assets 1,949 2,003 2,073 - -
  Previous Quarter
ending 03/31/25
Current Quarter
ending 06/30/25
Next Quarter
ending 09/30/25
Current Year
ending 12/31/25
Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts 1 - - 4 4
Average Estimate 0.350 EUR - - 1.358 EUR 1.580 EUR
Year Ago 0.355 EUR - - 0.667 EUR -
Publish Date 4/30/2025 - - - -
Revenue Estimates
No. of Analysts 2 - - 4 4
Average Estimate 286 EUR - - 1,193 EUR 1,234 EUR
Year Ago 285 EUR - - 1,154 EUR -
Publish Date 4/30/2025 - - - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. EUR

2024 2023 2022 2021 2020 2019 2018
Sales 1,153.99 1,187.66 1,129.74 1,025.32 837.26 745.81 717.02
Change of sales in % -2.84 5.13 10.18 22.46 12.26 4.01 23.07
Gross profit on sales 289.78 298.84 299.14 285.89 282.05 250.55 290.25
Gross profit on sales change in % -3.03 -0.10 4.63 1.36 12.57 -13.68 43.12
Operating income 89.62 155.16 126.65 123.02 136.86 108.65 132.88
Operating income change in % -42.24 22.51 2.95 -10.11 25.97 -18.24 66.53
Income before tax 62.69 72.05 106.92 97.84 111.36 109.53 129.04
Income before tax change in % -12.99 -32.61 9.27 -12.14 1.67 -15.12 93.49
Income after tax 34.60 45.92 73.41 68.97 73.19 65.82 92.34
Income after tax change in % -24.65 -37.45 6.44 -5.77 11.20 -28.72 194.91

Balance Sheet in Mio. EUR

2024 2023 2022 2021 2020 2019 2018
Total liabilities 1,401.22 1,319.32 1,322.20 1,246.93 963.61 837.43 606.73
Long-term liabilities per share 20.68 18.65 18.12 16.22 12.53 12.42 8.78
Equity 648.31 669.27 673.82 612.28 638.94 259.92 273.00
Equity change in % -2.96 -0.71 9.86 -4.16 146.49 -4.35 15.68
Balance sheet total 2,049.53 1,988.60 1,996.02 1,859.21 1,602.54 1,097.34 879.73
Balance sheet total change in % 3.06 -0.37 7.36 16.02 46.04 24.74 3.69

Key Data in EUR

2024 2023 2022 2021 2020 2019 2018
Sales per share 21.86 22.64 21.61 19.36 15.58 15.09 14.36
P/E ratio (year end quote, basic EPS) 32.62 43.12 25.60 53.98 57.71 46.89 21.55
P/E ratio (year end quote, diluted EPS) 33.20 43.30 25.63 54.65 57.71 47.87 21.87
Dividend yield in % 0.23 2.64 1.39 0.70 0.64 0.78 1.24
Equity ratio in % 31.63 33.66 33.76 32.93 39.87 23.69 31.03
Debt ratio in % 68.37 66.34 66.24 67.07 60.13 76.31 68.97

CompuGroup Medical Dividend Calendar

Date Name Dividend *yield Currency
2024 CompuGroup Medical SE & Co. KGaA 0.05 0.23 EUR
2023 CompuGroup Medical SE & Co. KGaA 1.00 2.64 EUR
2022 CompuGroup Medical SE & Co. KGaA 0.50 1.39 EUR
2021 CompuGroup Medical SE & Co. KGaA 0.50 0.70 EUR
2020 CompuGroup Medical SE & Co. KGaA 0.50 0.64 EUR
2019 CompuGroup Medical SE & Co. KGaA 0.50 0.78 EUR
2018 CompuGroup Medical SE & Co. KGaA 0.50 1.24 EUR
2017 CompuGroup Medical SE & Co. KGaA 0.35 0.64 EUR
2016 CompuGroup Medical SE & Co. KGaA 0.35 0.90 EUR
2015 CompuGroup Medical SE & Co. KGaA 0.35 1.04 EUR
2014 CompuGroup Medical SE & Co. KGaA 0.35 1.76 EUR
2013 CompuGroup Medical SE & Co. KGaA 0.35 1.89 EUR
2012 CompuGroup Medical SE & Co. KGaA 0.35 2.39 EUR
2011 CompuGroup Medical SE & Co. KGaA 0.25 2.87 EUR
2010 CompuGroup Medical SE & Co. KGaA 0.25 2.26 EUR
2009 CompuGroup Medical SE & Co. KGaA 0.25 3.36 EUR
2008 CompuGroup Medical SE & Co. KGaA 0.00 0.00 EUR
2007 CompuGroup Medical SE & Co. KGaA 0.00 0.00 EUR
2006 CompuGroup Medical SE & Co. KGaA 0.00 0.00 EUR
2005 CompuGroup Medical SE & Co. KGaA 0.00 0.00 EUR
2004 CompuGroup Medical SE & Co. KGaA 0.00 0.00 EUR
2003 CompuGroup Medical SE & Co. KGaA 0.00 0.00 EUR
2002 CompuGroup Medical SE & Co. KGaA 0.00 0.00 EUR
2001 CompuGroup Medical SE & Co. KGaA 0.00 0.00 EUR
2000 CompuGroup Medical SE & Co. KGaA 0.03 2.88 EUR
*Yield of the Respective Date

CompuGroup Medical Calendar

Event Estimate Info Date
Earnings Report - Q2 2025 Earnings Release 07/31/2025
Annual General Meeting 0.670 EUR Annual General Meeting 08/01/2025
Earnings Report - Q3 2025 Earnings Release 11/06/2025
Earnings Report - Q4 2025 Earnings Release 02/11/2026
Earnings Report - Q1 2026 Earnings Release 05/13/2026
Earnings Report - Q2 2026 Earnings Release 07/30/2026

CompuGroup Medical Past Events

Event Actual EPS Info Date
Earnings Report -0.120 EUR Q4 2024 Earnings Release 03/06/2025
Earnings Report 0.170 EUR Q3 2024 Earnings Release 11/07/2024
Earnings Report 0.270 EUR Q2 2024 Earnings Release 07/15/2024
Annual General Meeting 0.880 EUR Annual General Meeting 05/22/2024
Earnings Report 0.350 EUR Q1 2024 Earnings Release 05/08/2024
Earnings Report -0.300 EUR Q4 2023 Earnings Release 02/07/2024
Earnings Report 0.310 EUR Q3 2023 Earnings Release 11/09/2023
Earnings Report 0.600 EUR Q2 2023 Earnings Release 08/10/2023
Annual General Meeting 1.410 EUR Annual General Meeting 05/17/2023
Earnings Report 0.280 EUR Q1 2023 Earnings Release 05/10/2023
Earnings Report 0.260 EUR Q4 2022 Earnings Release 02/09/2023
Earnings Report 0.560 EUR Q3 2022 Earnings Release 11/03/2022
Earnings Report 0.230 EUR Q2 2022 Earnings Release 08/04/2022
Annual General Meeting 1.300 EUR Annual General Meeting 05/19/2022
Earnings Report 0.350 EUR Q1 2022 Earnings Release 05/05/2022
Earnings Report 0.240 EUR Q4 2021 Earnings Release 03/10/2022

CompuGroup Medical Profile

CompuGroup Medical SE & Co. KGaA engages in the provision of e-Health solutions. Its software products are designed to support all medical and organizational activities in doctor’s office, pharmacies, laboratories and hospitals. It operates through the following segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), and Hospital Information Systems (HIS). The AIS segment includes developing and selling practice management software for registered physicians, medical care centers and physician networks. The PCS segment t focuses on developing and selling integrated administrative and billing-related software applications for pharmacies. The HIS segment handles clinical and administrative solutions for the inpatient sector, where health services are provided over a prolonged period of time through highly specialized, secondary care institutions. The company was founded by Frank Gotthardt in 1987 and is headquartered in Koblenz, Germany.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
7
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

CompuGroup Medical Management

Name Job
Philipp von Ilberg Chairman-Supervisory Board
Daniel Gotthardt Chief Executive Officer
Daniela Hommel Chief Financial Officer
Hannes Reichl Managing Director-Inpatient & Social Care
Frank Betz Member-Supervisory Board
Matthias Wilhelm Störmer Member-Supervisory Board
Ayfer Basal Member-Supervisory Board
Julia Mole Member-Supervisory Board
Martin Köhrmann Member-Supervisory Board
Ulrike Handel Member-Supervisory Board
Reinhard Lyhs Member-Supervisory Board
Adelheid Hegemann Member-Supervisory Board
Bettina Volkens Member-Supervisory Board
Ali Yener Member-Supervisory Board
Claudia Thomé Senior VP-IR & Head-Corporate Communications
Stefan Weinmann Vice Chairman-Supervisory Board